Top Markets
#1 Black Phoenix Black Phoenix +826.67%
#2 PondCoin PondCoin +33.13%
#3 pipedog pipedog +27.21%
#4 SAFEcoin SAFEcoin +26.63%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.03%
#6 Beam Beam +23.44%
#7 Bless Bless +22.53%
#8 Magma Finance Magma Finance +20.36%
#9 Seeker Seeker +18.55%
#10 Merlin's Seal BTC Merlin's Seal BTC +16.88%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Zenas BioPharma, Inc. Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

ZBIO
Clasificación en acciones #6354
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm,... Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
Precio por acción
$33.00
Capitalización bursátil
$2.08B
Cambio (1 día)
-0.12%
Cambio (1 año)
97.49%
País
US
Comercio Zenas BioPharma, Inc. (ZBIO)

Categoría

Healthcare
Ganancias de Zenas BioPharma, Inc. (ZBIO)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Zenas BioPharma, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Zenas BioPharma, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH